Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 7 studies | 43% ± 15% | |
| glutamatergic neuron | 5 studies | 27% ± 16% | |
| GABAergic neuron | 4 studies | 37% ± 18% | |
| interneuron | 4 studies | 55% ± 20% | |
| neuron | 3 studies | 28% ± 18% | |
| GABAergic amacrine cell | 3 studies | 24% ± 6% | |
| oligodendrocyte precursor cell | 3 studies | 24% ± 9% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 44% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 2445.59 | 2641 / 2642 | 5% | 0.08 | 32 / 705 |
| ovary | 47% | 131.70 | 85 / 180 | 50% | 1.33 | 213 / 430 |
| thymus | 93% | 368.73 | 609 / 653 | 0% | 0.00 | 1 / 605 |
| blood vessel | 82% | 258.85 | 1096 / 1335 | 0% | 0 | 0 / 0 |
| uterus | 78% | 231.95 | 132 / 170 | 0% | 0.00 | 1 / 459 |
| intestine | 59% | 211.93 | 568 / 966 | 1% | 0.01 | 4 / 527 |
| bladder | 57% | 190.00 | 12 / 21 | 0% | 0 | 0 / 504 |
| esophagus | 49% | 136.79 | 703 / 1445 | 3% | 0.13 | 5 / 183 |
| prostate | 44% | 109.31 | 108 / 245 | 0% | 0 | 0 / 502 |
| lung | 42% | 100.97 | 245 / 578 | 0% | 0 | 0 / 1155 |
| adipose | 30% | 69.21 | 357 / 1204 | 0% | 0 | 0 / 0 |
| skin | 28% | 115.68 | 514 / 1809 | 0% | 0 | 0 / 472 |
| stomach | 27% | 77.11 | 98 / 359 | 1% | 0.02 | 3 / 286 |
| muscle | 19% | 44.26 | 156 / 803 | 0% | 0 | 0 / 0 |
| breast | 19% | 41.88 | 88 / 459 | 0% | 0 | 0 / 1118 |
| heart | 15% | 32.62 | 127 / 861 | 0% | 0 | 0 / 0 |
| kidney | 7% | 16.42 | 6 / 89 | 0% | 0 | 0 / 901 |
| adrenal gland | 6% | 13.66 | 15 / 258 | 0% | 0 | 0 / 230 |
| pancreas | 0% | 0.62 | 1 / 328 | 0% | 0 | 0 / 178 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 0% | 0 | 0 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0005886 | Cellular component | plasma membrane |
| Gene name | TMEFF1 |
| Protein name | Tomoregulin-1 (TR-1) (H7365) (Transmembrane protein with EGF-like and one follistatin-like domain) |
| Synonyms | C9orf2 |
| Description | FUNCTION: May inhibit NODAL and BMP signaling during neural patterning (By similarity). May be a tumor suppressor in brain cancers. . |
| Accessions | ENST00000374879.5 [Q8IYR6-1] Q8IYR6 |